Records containing: Muscular Disorders, Atrophic
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-06-05A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Human Allogeneic Cardiosphere-Derived Cells for the Treatment of Duchenne Muscular Dystrophy
-
CLINICAL_TRIALS study record update · 2026-04-27Managed Access to Investigational Use of AOC 1044 in Participants With DMD Mutations Amenable to Exon 44 Skipping
-
CLINICAL_TRIALS study record update · 2026-04-13Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)
-
CLINICAL_TRIALS study record update · 2026-04-08Managed Access to Investigational Use of AOC 1044 in Participants With DMD Mutations Amenable to Exon 44 Skipping
-
CLINICAL_TRIALS study record update · 2026-03-10A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-05Polyphenols From Nonalcoholic Red Wine and Healthy Aging: an Opportunity to Understand Diet Modulation of the Aging Process From a Multidimensional Perspective
-
CLINICAL_TRIALS study record update · 2025-12-17A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Human Allogeneic Cardiosphere-Derived Cells for the Treatment of Duchenne Muscular Dystrophy
-
CLINICAL_TRIALS study record update · 2025-10-08A Phase 2 Extension Study to Evaluate the Long-Term Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of AOC 1001 Administered Intravenously to Adult Myotonic Dystrophy Type 1 (DM1) Patients
-
CLINICAL_TRIALS study record update · 2025-02-24A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
-
CLINICAL_TRIALS study record update · 2024-12-02Molecular Regulation of Skeletal Muscle Anabolic Resistance to Dietary Protein in Response to Injury-mediated Muscle Disuse
-
CLINICAL_TRIALS study record update · 2024-04-30Changes in Activity of Erector Spinae and Gluteus Medius Muscles With the Presence of Simulated Lower Limb Dysmetria
-
CLINICAL_TRIALS study record update · 2024-03-04Bruxism and Underlying Psichological Factors
-
CLINICAL_TRIALS study record update · 2023-04-18A Phase 1, Open-label Study in Healthy Male Subjects of the Absorption, Metabolism, Excretion, and Pharmacokinetics of EDG-5506 and an Absolute Bioavailability Study Using Radiolabeled EDG-5506
-
CLINICAL_TRIALS study record update · 2020-08-11A Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
-
CLINICAL_TRIALS study record update · 2020-08-04A Phase 3 Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Dystrophinopathy
-
CLINICAL_TRIALS study record update · 2012-10-18Comparison of Magnetic Resonance (MR) Imaging Against Clinical Criteria in the Diagnosis and Monitoring of Adult Idiopathic Myopathy